Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
about
Radiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesTreatment of colorectal cancer in the elderlyS-1-Based versus capecitabine-based preoperative chemoradiotherapy in the treatment of locally advanced rectal cancer: a matched-pair analysis.Overview of radiation therapy for treating rectal cancer.Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.Rectal cancer surgery in older people does not increase postoperative complications--a retrospective analysis.Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?Identification of locally advanced rectal cancer with low risk of local recurrenceShort Course Radiation in the Treatment of Localized Rectal Cancer: A Systematic Review and Meta-AnalysisThe prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal CancerPreoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial.Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.Knowledge, Attitudes, and Practices Related to Preoperative Chemoradiotherapy in Rectal Cancer PatientsProtocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR).Local advanced rectal cancer perforation in the midst of preoperative chemoradiotherapy: A case report and literature reviewGerm line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review.Biological mesh reconstruction of the pelvic floor following abdominoperineal excision for cancer: A review.Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy.Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy.Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes.Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer.Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer.Eastern Canadian Colorectal Cancer Consensus Conference 2017
P2860
Q26738806-6E24FF5A-D026-4C1F-A64E-A4CCF9351D55Q26781457-4A50DBA0-4E8D-40F1-A38E-821E319FE818Q34121751-670F80EA-821D-4D64-B103-C5711253F785Q34136267-BE961E4A-620D-4D8A-BE6C-C2FE6DDBD2F4Q34537462-95007F8A-AF23-42DE-8512-E48938B624F2Q34643352-5E21A9A8-F5BF-44A2-9537-42972EA0A19AQ34719568-55CAE64B-CE84-4F86-A8EF-3C0EAC1C3F9FQ35023082-68D8F2BB-699C-4AC7-843C-86C41F8D4A7BQ35700812-CE1FCD8D-EEDE-4425-AC7F-AB5CB60422AEQ35867312-97E5066E-7AA0-4F6E-BCE7-550204D65C24Q36187080-F1222E30-B9DD-4814-A66C-1932D9CE442BQ36208490-03C8DB8B-6138-4A47-B2E8-D9FDBF3BA5F1Q36457414-31C32A77-4C72-4031-8B14-934878A4D455Q36621562-F252BFC9-9A31-47F4-9035-2DE8369CC616Q37330008-5C78A870-D16E-419C-AF49-B2DC23DCB8B8Q37454832-101794C6-A412-4DE4-9674-CF30B0F26BD1Q37587488-3F7F62F9-8D3E-4974-B43F-D17312E248B4Q38367771-C7FE2FC2-2E74-41EF-91DE-B22B862E547FQ38562040-9064B344-166B-48DE-9C45-F334EC298867Q38670419-8F29A9F1-ED12-454E-9FF3-92F4E147360FQ38714691-F5C68A68-3D41-435C-B172-3F72FEAADBF5Q47228177-5C2DB02D-DE9A-4AD7-8CF7-844D267227BFQ50052519-074E9134-25C5-45F4-BB74-12E5EF21B55BQ50091631-7F032FE7-9365-4161-AA52-EE70CC1C5CB0Q55077052-F2C3AF72-9DA7-4F3E-BA41-90A6EE22BBCDQ55241291-00B2F941-6533-44FF-A2B6-0C9ABFDB4384Q58783221-CECE42A9-CB59-4DDD-9EE1-A564BACEE457
P2860
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@ast
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en-gb
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@nl
type
label
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@ast
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en-gb
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@nl
prefLabel
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@ast
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en-gb
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@nl
P2860
P3181
P1476
Preoperative chemoradiation ve ...... d III resectable rectal cancer
@en
P2093
Laura De Caluwé
Yves Van Nieuwenhove
P2860
P3181
P356
10.1002/14651858.CD006041.PUB3
P50
P577
2013-02-28T00:00:00Z